STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding.

Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff. The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures.

Altschuler and Ziff’s relationship goes back to the mid-2010s, when Altschuler was chief executive of the well-known research hospital Children’s Hospital of Philadelphia, or CHOP. Ziff, who is one of the heirs to the Ziff Davis publishing fortune, was sitting on CHOP’s board of trustees.

Continue to STAT+ to read the full story…